[{"id":"fa643f54-6dfa-417b-ad3a-9c313ba284be","acronym":"","url":"https://clinicaltrials.gov/study/NCT03842085","created_at":"2021-01-18T18:58:00.207Z","updated_at":"2024-07-02T16:35:32.413Z","phase":"Phase 1","brief_title":"Phase I Clinical Study of MBS301 in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor","source_id_and_acronym":"NCT03842085","lead_sponsor":"Beijing Mabworks Biotech Co., Ltd.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MBS301"],"overall_status":"Recruiting","enrollment":" Enrollment 34","initiation":"Initiation: 04/11/2019","start_date":" 04/11/2019","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-10-20"}]